Acadia Healthcare price target lowered to $20 from $28 at Barclays

Barclays lowered the firm’s price target on Acadia Healthcare (ACHC) to $20 from $28 and keeps an Equal Weight rating on the shares post the Q2 report. Despite larger than expected Tennessee payments, the company still lowered its 2025 EBITDA guidance, including a $30M core reduction due to slower volumes, the analyst tells investors in a research note.